Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
CC transcript
Inv. presentation
INTEST CORP (INTT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/10/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/10/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/10/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/10/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 8-K Quarterly results
Docs: "inTEST Reports Record Revenue of $32.6 Million for the 2023 Second Quarter with Net Earnings Growth of 32% Year-over-Year"
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/26/2023 SD Form SD - Specialized disclosure report:
05/11/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Sales Agreement, by and between inTEST Corporation and Lake Street Capital Markets, LLC",
"Opinion of Harter Secrest & Emery LLP"
05/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 8-K Quarterly results
Docs: "inTEST Consistent Strong Execution Validated by Revenue Growth of 32.5% Year-over-year in First Quarter 2023"
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
03/29/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
03/22/2023 10-K Annual Report for the period ended December 31, 2022
03/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/03/2023 8-K Quarterly results
Docs: "Solid Execution of inTEST’s 5-Point Strategy Drove Record Fourth Quarter and Full Year 2022 Revenue"
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/06/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/04/2022 8-K Quarterly results
10/03/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
09/26/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Third Amendment to Amended and Restated Loan and Security Agreement, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc. and M&T Bank",
"Third Amended and Restated Delayed Draw Term Note 1A",
"inTEST Expands Funding for Greater Financial Flexibility MT. LAUREL, NJ –September 26, 2022 – inTEST Corporation , a global supplier of innovative test and process solutions for use in manufacturing and testing in key target markets which include automotive, defense/aerospace, industrial, life sciences, security, and semiconductor, announced today that it has executed an amendment to its loan agreement with M&T Bank to expand the existing non-revolving delayed draw term loan facility by $25.5 million to $50.5 million. After borrowings of $20.5 million in the fourth quarter of 2021, this amendment raises the remaining available funding under the term loan facility to $30 million. The maturity date for draws under the expanded term loan facility has been extended to September 2027. This exte..."
08/12/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
06/27/2022 8-K Quarterly results
06/13/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/26/2022 SD Form SD - Specialized disclosure report:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy